The physiology of atrial naturiuretic peptide (ANP) secretion was studied in normotensive subjects and hypertensive patients both young and old. Basal plasma ANP concentration was least in young normotensives, intermediate in old normotensives and young hypertensives, and highest in old hypertensives. Nifedipine, a known stimulator of ANP secretion, acutely increased plasma ANP in young and old normotensive subjects but not in young hypertensive patients and half of the old hypertensive patients. Increase in serum ANP level in response to nifedipine did not augment its hypotensive effect. However, the increase of aldosterone in response to nifedipine-induced rise in plasma renin activity (PRA) seemed to be suppressed by elevated ANP.
Get full access to this article
View all access options for this article.
References
1.
Braunwald E.: Mechanism of action of calcium channel blocking agents. N Engl J Med307:1618-1627, 1982.
2.
Janis RA, Scriabine A.: Sites of action of Ca2+ channel inhibitors. Biochem Parmacol32:3499-3507. 1983.
3.
Klutsch K., Schmidt P., Grosswendt J.: Der Einfluss von Bay a 1040 (Nifedipine) auf die Nierenfunktion des Hypertonikers . Arzneim Forsch22:377-380, 1972.
4.
Graves J.Kenamond TG, Whittier FC: Acute effects of nifedipine on renal electrolyte excretion in normal and hypertensive subjects. Am J Med Sci296:114-118, 1988.
5.
Madeddu P., Oppes M., Soro A., et al: Natriuretic effect of acute nifedipine administration is not mediated by the renal kallikrein-kinin system. J Cardiovasc Pharmacol9:536-540, 1987.
6.
Rappelli A., Dessi-Fulgheri P., Madeddu P., et al: Studies on the natriuretic effect of nifedipine in hypertensive patients: Increase in levels of plasma atrial natriuretic factor without participation of the renal kallikrein-kinin system. J Hypertension5 (suppl 4):s61-s65, 1987.
7.
Shima J., Ogihara T., Hara H., et al: Effects of calcium antagonist on the secretion of atrial natriuretic peptides in normal volunteers. Curr Ther Res42:115-123, 1987.
8.
Hiramatsu K. , Yamagishi F., Kubota T., et al: Acute effect of calcium antagonist, nifedipine, on blood pressure, pulse rate, renin-angiotensin-aldosterone system in patients with essential hypertension. Am Heart J104:1346-1350, 1982.
9.
Pedersen OL, Mikkelsen E., Christensen NJ, et al: Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension. Eur J Clin Pharmacol15:235-240, 1979.
10.
Miller JA, McLean KA, Sumner DJ, et al: The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man. Eur J Clin Pharmacol24:315-321, 1983.
11.
Ohashi M., Fujio N., Nawata H., et al: High plasma concentrations of human atrial natriuretic peptide in aged men. J Clin Endocrinol Metab64:81-85, 1987.
12.
Larochelle P., Cusson JR, Gutkowska J., et al: Mesure de facteur natriuretique de l'oreillette chez des patients avec hypertension essentielle et renovasculaire . Arch Mal Coeur80:976-981, 1987.
13.
Sugawara A. , Nakao K., Kono T., et al: Atrial natriuretic factor in essential hypertension and adrenal disorders. HypertensionII(Suppl I):I-212-216, 1988 .
14.
Iwasaki T., Niwa A., Shinida T., et al: Effects of calcium antagonists and nitroglycerin on atrial natriuretic peptide in normal subjects and patients with essential hypertension. Angiol40:24-28, 1989.
15.
Shigematsu S., Iwasaki T., Aizawa T., et al: Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease. Horm Metab Res21:514-518, 1989.
16.
Haller Bgd, Zust H., Shaw S., et al: Effects of posture and aging on circulating atrial natriuretic peptide levels in man. J Hypertension5:551-556, 1987.
Kohno M., Yasunari K., Matsura T., et al: Circulating atrial natriuretic poplypeptide in essential hypertension . Am Heart J113:1160-1163, 1987 .
19.
Crozier IG, Nicholls MG, Ikram H., et al: Relationship between left atrial diameter and plasma atrial natriuretic peptide, renin and vasopressin. Am J Cardiol58:1134-1136, 1986.
20.
Richards AM , McDonald D., Fitzpatrick MA, et al: Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab67:1134-1139, 1988.
21.
Cusson JR, Hamet P., Gutkowska J., et al: Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension. J Hypertension5:435-443, 1987.
22.
Arendt RM, Stangl E., Zahringer J., et al: Demonstration and characterization of alpha-human atrial natriuretic factor in human plasma. FEBS Lett189:57-61, 1985.
23.
McMurray J. , Coutie Wjr, McFarlane L., et al: Atrial natriuretic factor inhibits ACTH stimulated aldosterone, but not cortisol, secretion in man. Eur J Clin Pharmacol35:409-412, 1988.
24.
Richards AM , Tonolo G., Montorsi P., et al: Low dose infusions of 26-and 28-amino acid human atrial natriuretic peptides in normal man. J Clin Endocrinol Metab66:465-472, 1988.
25.
Metzler CH, Ramsay DJ: Physiological doses of atrial peptide inhibit angiotensin 11-stimulated aldosterone secretion. Am J Physiol256: R1155-R1159, 1989.
